Antonello Pani

4.8k total citations
17 papers, 782 citations indexed

About

Antonello Pani is a scholar working on Nephrology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Antonello Pani has authored 17 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 5 papers in Pathology and Forensic Medicine and 5 papers in Hematology. Recurrent topics in Antonello Pani's work include Renal Diseases and Glomerulopathies (15 papers), Chronic Kidney Disease and Diabetes (9 papers) and Platelet Disorders and Treatments (4 papers). Antonello Pani is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Chronic Kidney Disease and Diabetes (9 papers) and Platelet Disorders and Treatments (4 papers). Antonello Pani collaborates with scholars based in Italy, Canada and Switzerland. Antonello Pani's co-authors include Claudio Pozzi, Lucia Del Vecchio, Patrizia Scaini, Simeone Andrulli, Francesco Locatelli, Daniel C. Cattran, Hong Zhang, H. Terence Cook, Rosanna Coppo and Suxia Wang and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

Antonello Pani

16 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonello Pani Italy 11 693 281 197 155 102 17 782
Britta Otte Germany 6 490 0.7× 199 0.7× 90 0.5× 179 1.2× 74 0.7× 8 627
L. Nicholas Cossey United States 12 436 0.6× 153 0.5× 153 0.8× 56 0.4× 56 0.5× 19 575
A. Ragni Italy 8 572 0.8× 144 0.5× 121 0.6× 129 0.8× 84 0.8× 11 613
Shin Okuyama Japan 13 321 0.5× 115 0.4× 188 1.0× 43 0.3× 82 0.8× 38 527
Sumio Tateno Japan 12 516 0.7× 145 0.5× 102 0.5× 107 0.7× 60 0.6× 25 628
Takashi Ando Japan 11 387 0.6× 111 0.4× 73 0.4× 72 0.5× 34 0.3× 19 502
Ari Shimizu Japan 12 280 0.4× 88 0.3× 69 0.4× 86 0.6× 48 0.5× 29 381
Hideki Yamaya Japan 12 158 0.2× 97 0.3× 61 0.3× 266 1.7× 61 0.6× 28 625
Misao Tsukada Japan 11 318 0.5× 65 0.2× 80 0.4× 68 0.4× 36 0.4× 31 390

Countries citing papers authored by Antonello Pani

Since Specialization
Citations

This map shows the geographic impact of Antonello Pani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonello Pani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonello Pani more than expected).

Fields of papers citing papers by Antonello Pani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonello Pani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonello Pani. The network helps show where Antonello Pani may publish in the future.

Co-authorship network of co-authors of Antonello Pani

This figure shows the co-authorship network connecting the top 25 collaborators of Antonello Pani. A scholar is included among the top collaborators of Antonello Pani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonello Pani. Antonello Pani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Baragetti, Ivano, Lucia Del Vecchio, Francesca Ferrario, et al.. (2024). The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort. Journal of Nephrology. 38(1). 225–234. 3 indexed citations
2.
Piras, Doloretta, Nicola Lepori, Gianfranca Cabiddu, & Antonello Pani. (2022). How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside. Journal of Personalized Medicine. 12(2). 193–193. 2 indexed citations
3.
Scolari, Francesco, Elisa Delbarba, Domenico Santoro, et al.. (2021). Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial. Journal of the American Society of Nephrology. 32(4). 972–982. 131 indexed citations
4.
Delbarba, Elisa, Domenico Santoro, Loreto Gesualdo, et al.. (2020). Rituximab vs. Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Trial. Journal of the American Society of Nephrology. 31(10S). B9–B9. 1 indexed citations
5.
Alberici, Federico, Ivano Baragetti, Francesca Ferrario, et al.. (2020). MO040LONG-TERM FOLLOW-UP OF IGA NEPHROPATHY PATIENTS AT HIGH RISK OF PROGRESSION ACCORDING TO THE THERAPEUTIC APPROACH EMPLOYED: A MULTICENTER RETROSPECTIVE STUDY OF 947 PATIENTS. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
6.
Scolari, Francesco, Nadia Dallera, Loreto Gesualdo, et al.. (2019). Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial. BMJ Open. 9(12). e029232–e029232. 14 indexed citations
7.
Haas, Mark, Jacobien C. Verhave, Zhihong Liu, et al.. (2016). A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy. Journal of the American Society of Nephrology. 28(2). 691–701. 216 indexed citations
8.
Tinelli, Carmine, Francesca Ferrario, Bianca Visciano, et al.. (2016). Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy. PLoS ONE. 11(7). e0158584–e0158584. 9 indexed citations
9.
Tinelli, Carmine, Francesca Ferrario, Antonello Pani, et al.. (2016). Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 11(6). 973–981. 38 indexed citations
10.
Piccoli, Giorgina Barbara, G. Grassi, Gianfranca Cabiddu, et al.. (2015). Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease. The Review of Diabetic Studies. 12(1-2). 87–109. 66 indexed citations
11.
Altieri, Paolo, et al.. (2015). Is Renal Vasculitis in Patients with Systemic Lupus erythematosus a Bad Prognostic Factor?. Contributions to nephrology. 99. 72–78.
12.
Pozzi, Claudio, Simeone Andrulli, Antonello Pani, et al.. (2012). IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine. Journal of Nephrology. 26(1). 86–93. 40 indexed citations
13.
Pani, Antonello. (2012). Standard immunosuppressive therapy of immune-mediated glomerular diseases. Autoimmunity Reviews. 12(8). 848–853. 23 indexed citations
14.
Pozzi, Claudio, Simeone Andrulli, Antonello Pani, et al.. (2010). Addition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy. Journal of the American Society of Nephrology. 21(10). 1783–1790. 92 indexed citations
15.
Locatelli, Francesco, Claudio Pozzi, Simeone Andrulli, et al.. (2000). Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.. PubMed. 12(5). 308–11. 18 indexed citations
16.
Ponticelli, Claudio, Giovanni Banfi, Bruno Mario Cesana, et al.. (1999). Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?. American Journal of Kidney Diseases. 34(4). 618–625. 90 indexed citations
17.
Andrews, Peter, Antonello Pani, Wuding Zhou, & Steven H. Sacks. (1994). LOCAL TRANSCRIPTION OF COMPLEMENT C3 IN HUMAN ALLOGRAFT REJECTION. Transplantation. 58(5). 637–640. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Britta Otte Breakdown of academic impact, for papers by L. Nicholas Cossey Breakdown of academic impact, for papers by A. Ragni Breakdown of academic impact, for papers by Shin Okuyama Breakdown of academic impact, for papers by Sumio Tateno Breakdown of academic impact, for papers by Takashi Ando Breakdown of academic impact, for papers by Ari Shimizu Breakdown of academic impact, for papers by Hideki Yamaya Breakdown of academic impact, for papers by Misao Tsukada
Rankless by CCL
2026